The pathogenesis of anaemia may be simple or complex and the differential d
iagnosis can be difficult. An appreciation of the erythropoietic processes
is required, together with regular review of investigations, to ensure that
appropriate protocols are adopted. The application of tests, which define
different facets of erythropoiesis, should be appropriate to the clinical c
ircumstances. In some situations, such as the anaemia of chronic disorders,
pregnancy and chronic renal failure, a detailed analysis of erythropoiesis
is often required.
Guidelines for investigating anaemia due to megaloblastosis or haemoglobino
pathy are well established, whereas disturbances of iron metabolism are oft
en difficult to classify. These require a clear distinction between storage
and functional iron to differentiate whether the defect is due to readily
treatable simple iron deficiency or more complex mechanisms, which do not r
espond to iron supplementation. Determination of red cell haemoglobin conte
nt, reticulocyte analysis and the assay of serum transferrin receptors are
new generation parameters developed to address this.
Practice pressures and new treatment options have contributed to investigat
ions becoming more complex, especially those of the secondary anaemias, as
new tests have become more readily available and often automated. This has
resulted in reduced turnaround times and clinical demand has driven request
patterns. Initiatives to develop evidence-based anaemia management protoco
ls are welcomed but, wherever possible, should be developed through collabo
ration between the haematology department and the user unit, and based on a
vailable guidelines.